AERI MENU

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 193.2 M 1.93238E+08 227 227 0.05% 0.000453578 188 K 187951
UBIO Proshares UltraPro Nasdaq Biotechnology 22.6 M 2.25789E+07 222 222 0.02% 0.000235138 18 K 17592
URTY ProShares UltraPro Russell2000 92.7 M 9.26625E+07 2,001 2001 0.01% 0.000107664 31 K 31173
UWM ProShares Ultra Russell2000 175.1 M 1.75075E+08 1,999 1999 0.02% 0.000153622 58 K 57680
IBB iShares Nasdaq Biotechnology Index Fund 7.0 B 7.03519E+09 216 216 0.12% 0.0012 8.2 M 8236040
IHE iShares U.S. Pharmaceutical ETF 330.8 M 3.30841E+08 45 45 0.33% 0.0033 1.1 M 1092790
ITOT iShares Core S&P Total U.S. Stock Market ETF 24.5 B 2.44501E+10 3,561 3561 0.0% 0 617 K 616659
IWM iShares Russell 2000 ETF 45.6 B 4.55937E+10 1,988 1988 0.04% 0.0004 18.2 M 1.82341E+07
IWO iShares Russell 2000 Growth ETF 9.2 B 9.19167E+09 1,154 1154 0.08% 0.0008 7.2 M 7241890
IWV iShares Russell 3000 ETF 9.9 B 9.92627E+09 2,885 2885 0.0% 0 270 K 270457
JKK iShares Morningstar Small-Cap Growth ETF 213.5 M 2.13485E+08 244 244 0.12% 0.0012 252 K 251713
IEIH iShares Evolved U.S. Innovative Healthcare ETF 5.2 M 5223360 218 218 0.06% 0.0006 3 K 3384
SCHA Schwab U.S. Small-Cap ETF 8.6 B 8.58121E+09 1,742 1742 0.03% 0.0003 2.4 M 2356027
SCHB Schwab U.S. Broad Market ETF 15.7 B 1.57025E+10 2,501 2501 0.0% 0 381 K 381171
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.01% 5.1E-05 74 K 74459
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 369 369 0.02% 0.000193725 296 K 296044
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000185257 389 K 389394